The trial will compare the safety and efficacy of equecabtagene autoleucel versus standard therapies in r/r MM patients.
FDA review uncertainty, failed phase 3 for ersodetug in HI, high-risk upLIFT trial, tight cash runway—read more macro ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...
Why More L&D Teams Are Turning to 90-Minute White-Label Training Packages Dickson, Australia - March 30, 2026 / ...
Early F‑VASI50 responses were associated with VitiQoL improvement without consistent DLQI separation, reinforcing instrument sensitivity differences for vitiligo-specific burden. By week 104, ...
Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...
According to the Marquette Law School Poll, 43% of registered Wisconsin voters said they had a favorable view of Trump, while ...
Research by an Indiana University faculty member is at the heart of new bipartisan legislation that would amend the Federal ...
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
LetsGetChecked is an exclusively telehealth diagnostics brand that specializes in at-home lab testing. We’ve picked them as ...
The MarketWatch News Department was not involved in the creation of this content.-- Raised over $20 million in gross proceeds in 2025 and held $11.9 million in cash and cash equiv ...
The survey found that only 28% of Americans hold a favorable view of the Democratic Party, while 32% view the Republican ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results